Pulmonx price target lowered to $16 from $17 at Stifel
The Fly

Pulmonx price target lowered to $16 from $17 at Stifel

Stifel lowered the firm’s price target on Pulmonx (LUNG) to $16 from $17 and keeps a Buy rating on the shares. Pulmonx delivered solid outperformance in Q3 despite a seasonally slower operating environment in the quarter, aided by continued progress on all three of its commercial initiatives, the analyst tells investors in a research note. The firm views Pulmonx’s the quarter and enhanced strategic initiatives positively for the company’s rest-of-year and set up for 2025 and beyond.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App